PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Sep-2022 Dupixent® (dupilumab) late-breaking Phase 3 data at EADV 2022 showed significant improvements in signs and symptoms of prurigo nodularis Sanofi
09-Sep-2022 Teva announces new positive AJOVY®▼ (fremanezumab) real world data from its migraine prevention study, PEARL and welcomes updated European Headache Federation guidelines on the use of CGRP mAbs Teva Pharmaceuticals
09-Sep-2022 Medacta Group SA reports strong revenue growth of 19.0% and adjusted EBITDA margin of 27.5% in the first semester 2022 Medacta Group SA
09-Sep-2022 Orthotic Devices, Casts and Splints Market Overview, High Growth Opportunities, Segmentation, Trends By 2024 MARKITWIRED
09-Sep-2022 Medical Cannula Market Segmentation by Revenue, Present & Future Scenario To 2030 MARKITWIRED
09-Sep-2022 Preterm Birth Prevention and Management Market By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2029 MARKITWIRED
09-Sep-2022 Home Healthcare Market Share, Size, Revenue And Growth Rate Till 2030 MARKITWIRED
09-Sep-2022 Oscillating Positive Expiratory Pressure (OPEP) Devices Market Comprehensive Study Explores Huge Growth In Future MARKITWIRED
09-Sep-2022 CD Formulation Offers Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals CD Formulation
09-Sep-2022 ParkourSC Appoints Holly Roland as Chief Marketing Officer Businesswire
09-Sep-2022 Paysign, Inc. to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Businesswire
08-Sep-2022 Charles River Laboratories to Present at Baird and Morgan Stanley Conferences Businesswire
08-Sep-2022 Zymeworks Announces Filing and Mailing of Materials for the Special Meeting to Approve Redomicile to Delaware Businesswire
08-Sep-2022 Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors Businesswire
08-Sep-2022 Nanobiotix: Voting Rights and Shares Capital of the Company Businesswire
08-Sep-2022 Pipeline Therapeutics to Participate in the UBS Virtual Biotechnology Private Company Symposium Businesswire
08-Sep-2022 MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights Businesswire
08-Sep-2022 Des études démontrent l'efficacité d'AJOVY®▼ (frémanézumab) dans le traitement de la migraine chez des patients présentant une dépression comorbide Businesswire
08-Sep-2022 ExtractionTek Stainless Files IPRs Against Gene Pool Technologies to Protect Clients Businesswire
08-Sep-2022 Studien zeigen Wirksamkeit von AJOVY®▼ (Fremanezumab) bei der Behandlung von Migräne bei Patientinnen und Patienten mit komorbider Depression Businesswire